Literature DB >> 33721206

Icariside II promotes the differentiation of human amniotic mesenchymal stem cells into dopaminergic neuron-like cells.

Wei Kuang1, Tao Liu1, Fang He2, Limei Yu2, Qian Wang1, Changyin Yu3.   

Abstract

The purpose of this study is to observe the effect of icariside II (ICS II) on the differentiation of human amniotic mesenchymal stem cells (hAMSCs) into dopaminergic neuron-like cells, the involvement of PI3K signaling pathway inhibitors. After identifying hAMSCs by flow cytometry, hAMSCs were induced and treated with ICS II at 10 μmol/L, 3 μmol/L, 1 μmol/L, and 0 μmol/L. hAMSCs in the LY294002+3μM ICS II group were pretreated with 20 μmol/L LY294002, a PI3K-specific inhibitor, for 1 h, and then hAMSCs were induced with 3 μmol/L ICS II. On the 21st day of induction, immunofluorescence was used to detect expression of the neuronal nuclei (NeuN), neuron-specific enolase (NSE), microtubule-associated protein-2 (MAP-2), glial fibrillary acidic protein (GFAP), and tyrosine hydroxylase (TH) antigens in each induced cell group. Western blotting was used to detect the relative protein expression of NSE, MAP-2, GFAP, and TH. ELISA was used to detect the dopamine concentration in the induction medium supernatant of each group. After 21 d of ICS II induction, immunofluorescence showed that GFAP expression was not obvious in any hAMSC group. The NeuN, NSE, MAP-2, and TH fluorescent proteins were expressed in each group. NeuN was expressed in the nucleus and cytoplasm, while NSE, MAP-2, and TH were mainly expressed in the cytoplasm. The positive cell rates of NeuN, NSE, MAP-2, and TH in the 10 μmol/L, 3 μmol/L, and 1 μmol/L ICS II groups were higher than those in the LY294002+3μM ICS II and control groups. After 21 d of induction, the Western blot results showed that the protein expression levels of NSE, MAP-2, and TH in the 10 μmol/L, 3 μmol/L, and 1 μmol/L ICS II groups were significantly higher than those in the LY294002+3μM ICS II and control groups. The MAP-2 protein expression levels in the 10 μmol/L and 3 μmol/L groups were higher than that in the 1 μmol/L group. After 21 d of induction, the dopamine concentrations in the culture supernatants of the 10 μmol/L, 3 μmol/L, and 1 μmol/L ICS II groups were higher than those in the LY294002+3μM ICS II and control groups. In our experiment, ICS II induced hAMSCs to differentiate into dopaminergic neuron-like cells, and the optimal concentration range of ICS II was 3-10 μmol/L. Moreover, the PI3K signaling pathway is involved in the above differentiation process.

Entities:  

Keywords:  Differentiation; Dopaminergic neuron-like cells; Glial fibrillary acidic protein; Human amniotic mesenchymal stem cells; Icariside II; Microtubule-associated protein-2; Neuron-specific enolase; Neuronal nuclei; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2021        PMID: 33721206     DOI: 10.1007/s11626-021-00556-8

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  27 in total

1.  Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

Authors:  Sangmi Chung; Kai-C Sonntag; Therese Andersson; Lars M Bjorklund; Jae-Joon Park; Dong-Wook Kim; Un Jung Kang; Ole Isacson; Kwang-Soo Kim
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

2.  Icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells.

Authors:  K M Chen; B F Ge; H P Ma; X Y Liu; M H Bai; Y Wang
Journal:  Pharmazie       Date:  2005-12       Impact factor: 1.267

3.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

4.  Initiation of neuronal differentiation requires PI3-kinase/TOR signalling in the vertebrate neural tube.

Authors:  Katherine J Fishwick; Roman A Li; Pamela Halley; Peiyi Deng; Kate G Storey
Journal:  Dev Biol       Date:  2009-12-11       Impact factor: 3.582

5.  Human amniotic mesenchymal stem cells alleviate paraquat-induced pulmonary fibrosis in rats by inhibiting the inflammatory response.

Authors:  Fang He; Yuying Wang; Yuxiang Li; Limei Yu
Journal:  Life Sci       Date:  2020-01-08       Impact factor: 5.037

6.  Embryonic stem cell-derived neuronally committed precursor cells with reduced teratoma formation after transplantation into the lesioned adult mouse brain.

Authors:  Marcel Dihné; Christian Bernreuther; Christian Hagel; Kai O Wesche; Melitta Schachner
Journal:  Stem Cells       Date:  2006-02-02       Impact factor: 6.277

7.  Developing stem cell therapies for Parkinson's disease: waiting until the time is right.

Authors:  Roger A Barker
Journal:  Cell Stem Cell       Date:  2014-11-06       Impact factor: 24.633

8.  Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.

Authors:  Dandan Chen; Wenyu Fu; Wenxin Zhuang; Cui Lv; Fengjie Li; Xin Wang
Journal:  J Neurosci Res       Date:  2016-09-12       Impact factor: 4.164

Review 9.  Diagnosis and Treatment of Parkinson Disease: A Review.

Authors:  Melissa J Armstrong; Michael S Okun
Journal:  JAMA       Date:  2020-02-11       Impact factor: 56.272

Review 10.  Pharmacological effects of icariin.

Authors:  Chunyang He; Ze Wang; Jingshan Shi
Journal:  Adv Pharmacol       Date:  2020-01-13
View more
  1 in total

1.  Icariside II Attenuates Methamphetamine-Induced Neurotoxicity and Behavioral Impairments via Activating the Keap1-Nrf2 Pathway.

Authors:  Jian Huang; Jiuyang Ding; Zhuo Wang; Yanning Li; Yitong He; Xiaohan Wang; Haoliang Fan; Qiqian Xie; Pingming Qiu
Journal:  Oxid Med Cell Longev       Date:  2022-03-28       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.